Anthera Pharmaceuticals
(OTC) ANTH
Anthera Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$9.86M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
7.31 (High)
Dividend
$0.00
Beta (Volatility)
7.31 (High)
Price
$0.00
Volume
100,000
Open
$0.00
Price
$0.00
Volume
100,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
7.31 (High)
Price
$0.00
Volume
100,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ANTH News
ANTH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anthera Pharmaceuticals
ANTH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
35%
Return on Assets
-5%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
26.18M
Volume
100.00K
Short Interest
0.00%
Avg. Volume
3.02K
Financials (TTM)
Gross Profit
$281.00K
Operating Income
$36.43M
EBITDA
$26.59M
Operating Cash Flow
$36.90M
Capital Expenditure
$0.00
Free Cash Flow
$36.90M
Cash & ST Invst.
$2.20M
Total Debt
$0.00
Anthera Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$7.47K
+3.0%
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
21
N/A
Net Income
$4.43M
+62.1%
EBITDA
$10.81M
-2.4%
Quarterly Fundamentals
Net Cash
$8.09M
-60.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-4.61%
N/A
Return on Invested Capital
35.10%
N/A
Free Cash Flow
$9.38M
+34.5%
Operating Cash Flow
$9.38M
+34.5%